Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Other Non Operating Income (2017 - 2025)

BioCorRx's Other Non Operating Income history spans 7 years, with the latest figure at -$55000.0 for Q2 2025.

  • For Q2 2025, Other Non Operating Income changed N/A year-over-year to -$55000.0; the TTM value through Sep 2025 reached $65331.0, up 152.87%, while the annual FY2024 figure was $129282.0, 476.5% up from the prior year.
  • Other Non Operating Income for Q2 2025 was -$55000.0 at BioCorRx, up from -$132514.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $271240.0 in Q4 2021 and bottomed at -$132514.0 in Q1 2025.
  • The 5-year median for Other Non Operating Income is -$17136.0 (2022), against an average of $39756.4.